1. Home
  2. CVE Database
  3. CVE-2025-52653
HIGH · 7.6

CVE-2025-52653

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or ...

Vulnerability Description

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

CVSS Score

7.6

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
LOW
Availability
HIGH

Affected Products

VendorProductVersions
HcltechDryice Myxalytics6.6

Related Weaknesses (CWE)

CWE-79

References

FAQ

What is CVE-2025-52653?

CVE-2025-52653 is a vulnerability with a CVSS score of 7.6 (HIGH). HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or ...

How severe is CVE-2025-52653?

CVE-2025-52653 has been rated HIGH with a CVSS base score of 7.6/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2025-52653?

Check the references section above for vendor advisories and patch information. Affected products include: Hcltech Dryice Myxalytics.